EP4031109
EXTENDED RELEASE DOSAGE FORMS FOR TYK2 INHIBITORS
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
18.9.2020EP published:
18.2.2026EP application number:
20781718.0
EPO information:
European Patent Register
Max expiry date:
17.9.2040Expiry date:
17.9.2026
Title in English:
EXTENDED RELEASE DOSAGE FORMS FOR TYK2 INHIBITORSLanguage of the patent:
English
Timeline
Today
18.9.2020EP application
18.2.2026EP Publication
17.9.2026Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
BADAWY, Sherif Ibrahim FaragAddress:
Princeton, New Jersey 08543, US
Name:
BROWN, Jonathan R.Address:
Moreton Merseyside CH46 1QW, GB
Name:
CHOI, Candice Y.Address:
Princeton, New Jersey 08543, US
Name:
GESENBERG, ChristophAddress:
Princeton, New Jersey 08543, US
Name:
GRAY, VivienneAddress:
Moreton Merseyside CH46 1QW, GB
Name:
JONES, John WynneAddress:
Moreton Merseyside CH46 1QW, GB
Name:
KESTUR, UmeshAddress:
Princeton, New Jersey 08543, US
Name:
VIG, Balvinder S.Address:
Devens, Massachusetts 01434, US
Name:
YIN, Xiaotian, S.Address:
Princeton, New Jersey 08543, US
Name:
ZORDAN, Christopher A.Address:
Princeton, New Jersey 08543, US
Name:
BLOOM, CoreyAddress:
Bend, Oregon 97702, US
Name:
YATES, IanAddress:
Bend, Oregon 97701, US
Priority
Number:
201962902218 PDate:
18.9.2019Country:
US
Classification
Categories:
A61K 9/00, A61K 9/14, A61K 9/16, A61K 47/02, A61K 47/12, A61K 47/26, A61K 47/38, A61K 31/501, A61P 29/00, A61P 37/06